French regulator investigated over withdrawal delay of Servier's diabetes drug
This article was originally published in Scrip
Executive Summary
The French ministry of health has launched an investigation into why the 2009 marketing suspension of Servier's benfluorex (Mediator), a drug used to treat overweight diabetics which has been associated with up to 2,000 possible deaths and heart valve problems, was not ordered earlier.